Promising Clinical Trial Results For A Mesothelioma Immunotherapy Drug
Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released.
Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released.